- Home
- PHUN vs BRNS Comparison
PHUN vs BRNS Comparison
Compare PHUN & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHUN
- BRNS
- Stock Information
- Founded
- PHUN 2009
- BRNS 2016
- Country
- PHUN United States
- BRNS United Kingdom
- Employees
- PHUN N/A
- BRNS N/A
- Industry
- PHUN EDP Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- PHUN Technology
- BRNS Health Care
- Exchange
- PHUN Nasdaq
- BRNS Nasdaq
- Market Cap
- PHUN 53.3M
- BRNS 48.3M
- IPO Year
- PHUN N/A
- BRNS 2021
- Fundamental
- Price
- PHUN $2.77
- BRNS $1.05
- Analyst Decision
- PHUN Buy
- BRNS Strong Buy
- Analyst Count
- PHUN 2
- BRNS 1
- Target Price
- PHUN $7.75
- BRNS $3.00
- AVG Volume (30 Days)
- PHUN 209.9K
- BRNS 41.2K
- Earning Date
- PHUN 11-06-2025
- BRNS 11-05-2025
- Dividend Yield
- PHUN N/A
- BRNS N/A
- EPS Growth
- PHUN N/A
- BRNS N/A
- EPS
- PHUN N/A
- BRNS N/A
- Revenue
- PHUN $2,400,000.00
- BRNS $14,969,000.00
- Revenue This Year
- PHUN N/A
- BRNS N/A
- Revenue Next Year
- PHUN $53.29
- BRNS N/A
- P/E Ratio
- PHUN N/A
- BRNS N/A
- Revenue Growth
- PHUN N/A
- BRNS 1766.46
- 52 Week Low
- PHUN $2.22
- BRNS $0.64
- 52 Week High
- PHUN $14.60
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- PHUN 55.14
- BRNS 40.11
- Support Level
- PHUN $2.42
- BRNS $1.08
- Resistance Level
- PHUN $2.81
- BRNS $1.20
- Average True Range (ATR)
- PHUN 0.10
- BRNS 0.09
- MACD
- PHUN 0.04
- BRNS -0.01
- Stochastic Oscillator
- PHUN 89.74
- BRNS 3.23
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.